A study to assess the safety, tolerability and pharmacokinetics of AZD4041 in Healthy Volunteers

Trial Identifier:	D7460C00001
Sponsor:	AstraZeneca
Collaborator:	National Institutes of Health (NIH) Eolas Therapeutics INC.
NCTID::	NCT04076540
Start Date:	October 2019
Primary Completion Date:	January 2022
Study Completion Date:	January 2022

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Version

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
US, NV	Las Vegas, NV, US, 89113
US, TX	Austin, TX, US, 78744

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.